Savvy Advisors Inc. acquired a new stake in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,827 shares of the company's stock, valued at approximately $946,000.
A number of other hedge funds also recently made changes to their positions in CLX. Rockefeller Capital Management L.P. lifted its holdings in Clorox by 5.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 16,003 shares of the company's stock valued at $2,599,000 after purchasing an additional 847 shares during the last quarter. Heritage Trust Co bought a new stake in shares of Clorox during the 4th quarter worth about $466,000. Redwood Park Advisors LLC acquired a new position in Clorox in the 4th quarter valued at about $26,000. F M Investments LLC raised its holdings in Clorox by 17.9% in the 4th quarter. F M Investments LLC now owns 15,063 shares of the company's stock valued at $2,446,000 after acquiring an additional 2,291 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in Clorox during the fourth quarter worth approximately $37,935,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several analysts recently weighed in on CLX shares. Wells Fargo & Company dropped their price target on Clorox from $155.00 to $145.00 and set an "equal weight" rating for the company in a report on Wednesday. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a report on Friday, April 11th. Barclays cut their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. DA Davidson reduced their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Finally, Citigroup lowered their price objective on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $153.83.
View Our Latest Report on CLX
Clorox Trading Up 2.0 %
Shares of CLX stock traded up $2.80 on Friday, hitting $139.60. The company had a trading volume of 948,624 shares, compared to its average volume of 1,303,479. The stock's 50-day moving average is $146.57 and its two-hundred day moving average is $156.45. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market cap of $17.20 billion, a P/E ratio of 38.14, a P/E/G ratio of 2.62 and a beta of 0.61. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the company posted $2.16 EPS. On average, equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's payout ratio is 133.33%.
About Clorox
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.